Vimarsana
Biggest News Aggregation in the World

Nasdaq Bivi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Bivi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Bivi Today - Breaking & Trending Today

BioVie (BIVI) Scheduled to Post Earnings on Wednesday - Vimarsana News

BioVie (BIVI) Scheduled to Post Earnings on Wednesday

BioVie (NASDAQ:BIVI – Get Free Report) is scheduled to be releasing its earnings data on Wednesday, March 13th. BioVie (NASDAQ:BIVI – Get Free Report) last released its quarterly earnings data on Monday, February 12th. The company reported ($0.22) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.32) by $0.10. BioVie Stock Performance […]

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioVie Inc. - Vimarsana News

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioVie Inc.

NEW YORK, Feb. 24, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioVie Inc....

ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioVie Inc. - Vimarsana News

ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioVie Inc.

NEW YORK, Feb. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioVie Inc....

BioVie Inc. (NASDAQ:BIVI) Short Interest Down 36.3% in January - Vimarsana News

BioVie Inc. (NASDAQ:BIVI) Short Interest Down 36.3% in January

BioVie Inc. (NASDAQ:BIVI – Get Free Report) was the target of a large decline in short interest during the month of January. As of January 31st, there was short interest totalling 1,090,000 shares, a decline of 36.3% from the January 15th total of 1,710,000 shares. Based on an average daily trading volume, of 668,700 shares, […]

ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages BioVie - Vimarsana News

ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages BioVie

NEW YORK, Feb. 09, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioVie Inc....